**7. References**


Targeting the Mitochondria

ISSN 0887-2333

ISSN 0022-2631

0263-6484

751-766, ISSN 0021-9258

by Novel Adamantane-Containing 1,4-Dihydropyridine Compounds 271

Gazotti, P., Malmstron, K. & Crompton, M.A. (1979) Laboratory manual on transport and

Gornall, G., Bardawill, C.J. & David, M.M. (1949) Determination of serum proteins by means of

Halestrap AP, Woodfield KY, Connern CP. (1997) Oxidative stress, thiol reagents, and membrane

Kamo, N., Muratsugu, M., Hongoh, R. & Kobatake, N. (1979) Membrane potential of

Klimaviciusa, L., Klusa, V., Duburs, G., Kaasik, A., Kalda, A. & Zharkovsky, A. (2007) Distinct

Klusa, V. (1995) Cerebrocrast (IOS-1.1212). Neuroprotectant, cognition enhancer. *Drugs of the* 

Kones, R. (2010) Parkinson's disease: mitochondrial molecular pathology, inflammation, statins,

Kornhuber, J., Bormann, J., Hübers, M., Rusche, K. & Riederer, P. (1991) Effects of the 1-amino-

McStay, G.P., Clarke, S.J., Halestrap, A.P. (2002) Role of critical thiol groups on the matrix surface

McAllister, J., Ghosh, S., Berry, D., Park, M., Sadeghi, S., Wang, K.X., Parker, W.D. & Swerdlow,

Petrozzi, L., Ricci, G., Giglioli, N.J., Siciliano, G. & Mancuso, M. (2007) Mitochondria and

Pupure, J., Isajevs, S., Gordjushina, V., Taivans, I., Rumaks, J., Svirskis, S., Kratovska A., Dzirkale,

Vol.75, No.4, (February 2007), pp. 956-964, ISSN 0006-2952

Springer Verlag, ISBN 3540098445, New York, USA

No.6, (February 1997), pp. 3346-3354, ISSN 0021-9258

*Future*, Vol.20, No.2, pp. 135–138, ISSN 0377-8282

(August 2010), pp. 371-389, ISSN 0884-5336

1991), pp. 297-300, ISSN 0014-2999

2008), pp. 620-631, ISSN 1742-7835

541-548, ISSN 0264-6021

0144-8463

*Journal Published in Association with BIBRA,* Vol.23, No.7, (October 2009), pp. 1333–1341,

bioenergetics. In: *Membrane Biochemistry,* E. Carafoli & G. Semenza, (Eds.), 62-69,

the biuret reaction. *The Journal of Biological Chemistry,* Vol.177, No.2, (February 1949), pp.

potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. *The Journal of Biological Chemistry,* Vol.272,

mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in stade state. *The Journal of Membrane Biology,* Vol.49, No.2, (August 1979), pp. 105-121,

effects of atypical 1,4-dihydropyridines on 1-methyl-4-phenylpyridinium-induced toxicity. *Cell Biochemistry and Function*, Vol.25, No.1, (February 2007), pp. 15-21, ISSN

and therapeutic neuroprotective nutrition. *Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition,* Vol.25, No.4,

adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. *European Journal of Pharmacology,* Vol.206, No.4, (April

of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. *The Biochemical Journal,* Vol.367, No.2, (October 2002), pp.

R. H. (2007) Effects of memantine on mitochondrial function. *Biochemical Pharmacology*,

Neurodegeneration. *Bioscience Reports,* Vol.27, No.1-3, (June, 2007), pp. 87–104, ISSN

Z., Pilipenko, J., Duburs, G. & Klusa, V. (2008) Distinct influence of atypical 1,4 dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in micee ex vivo. *Basic & Clinical Pharmacology & Toxicology*, Vol.103, No.5, (November

separate sites. *The Journal of Biological Chemistry,* Vol.271, No.12, (March 1996), pp. 6746- 6751, ISSN 0021-9258


Costantini, P., Colonna, R., Bernardi, P. (1998) Induction of the mitochondrial permeability

Custódio, J. B. A., Palmeira, C. M., Moreno, A. J. M. & Wallace, K. B. (1998a) Acrylic acid induces

Custódio, J. B. A., Moreno, A. J. M. & Wallace, K. B. (1998b) Tamoxifen inhibits induction of the

De Araújo, D.P., Lobato, Rde. F., Cavalcanti, J.R., Sampaio, L.R., Araújo, P.V., Silva, M.C., Neves,

Ernster, L. & Nordenbrand, K. (1967) Microsomal lipid peroxidation. In: *Methods in Enzymology*,

Esposito, E. & Cuzzocrea S. (2010) Antiinflammatory activity of melatonin in central nervous

Fernandes, M.A.S., Santos, M.S., Vicente, J.A.F., Moreno, A.J.M., Velena, A., Duburs, G. &

Fernandes, M.A.S., Jurado, A.S., Videira, R.A., Santos, M.S., Moreno, A.J.M., Velena, A., Duburs,

Fernandes, M.A.S., Pereira, S.P.S., Jurado, A.S., Custódio, J.B.A., Santos, M.S., Moreno, A.J.M.,

Fernandes, M.A.S., Santos, M.S., Moreno, A.J.M., Chernova, L., Krauze, A., Duburs, G. & Vicente,

*Interactions*, Vol.173, No.3, (June 2008), pp. 195-204, ISSN 0009-2797

6751, ISSN 0021-9258

392, ISSN 0006-3002

ISSN 1096-6080

0036-8075

York, USA

1570-159X

ISSN 1567-7249

1567-7249

(February 2011), pp. 51-57, ISSN 0020-7454

separate sites. *The Journal of Biological Chemistry,* Vol.271, No.12, (March 1996), pp. 6746-

transition by N-ethylmaleimide depends on secondary oxidation of critical thiol groups. Potentiation by copper-ortho-phenanthroline without dimerization of the adenine nucleotide translocase. *Biochimica et Biophysica Acta,* Vol.1365, No.3, (July 1998), pp. 385-

the glutathione-independent mitochondrial permeability transition *in vitro*. *Toxicological Sciences : an Official Journal of the Society of Toxicology,* Vol.43, No.1 (May 1998), pp. 19-27,

mitochondrial permeability transition by Ca2+ and inorganic phosphate. *Toxicology and Applied Pharmacology,* Vol.152, No.1, (September 1998), pp. 10-17, ISSN 0041-008X Dawson, T.M. & Dawson, V.L. (2003) Molecular pathways of neurodegeneration in Parkinson's

disease. *Science (New York, N.Y.)*, Vol.302, No.5646, (October 2003), pp. 819–822, ISSN

K.R., Fonteles, M.M., Sousa, F.C. & Vasconcelos, S.M. (2011) The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. *The International Journal of Neuroscience*, Vol.121, No.2,

S.P. Colowick & N.O. Kaplan, (Eds.), 574-580, Academic Press, ISBN 0121820181, New

system. *Current Neuropharmacology*, Vol.8, No.3, (September 2008), pp. 228-242, ISSN

Oliveira, C.R. (2003) Effects of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone) on mitochondrial bioenergetics and oxidative stress: a comparative study. *Mitochondrion*, Vol.3, (August 2003), pp. 47-59,

G., Oliveira, C.R. & Vicente, J.A.F. (2005) Cerebrocrast promotes the cotransport of H+ and Cl- in rat liver mitochondria. *Mitochondrion,* Vol.5, (October 2005), pp. 341-351, ISSN

Duburs, G. & Vicente, J.A.F. (2008) Comparative effects of three 1,4-dihydropyridine derivatives [OSI-1210, OSI-1211 (etaftoron), and OSI-3802] on rat liver mitochondrial bioenergetics and on the physical properties of membrane lipid bilayers: relevance to the length of the alkoxyl chain in positions 3 and 5 of the DHP ring. *Chemico-Biological* 

J.A.F. (2009) Effects of 5-acetyl(carbamoyl)-6-methylsulfanyl-1,4-dihydropyridine-5 carbonitriles on rat liver mitochondrial function. *Toxicology in vitro: an International*  *Journal Published in Association with BIBRA,* Vol.23, No.7, (October 2009), pp. 1333–1341, ISSN 0887-2333


Ritz, B., Rhodes, S.L., Qian, L., Schernhammer, E., Olsen, J.H. & Friis, S. (2010) L-type calcium

Rojas, J. C., Saavedra, J. A. & Gonzalez-Lima, F. (2008) Neuroprotective effects of memantine in a

Sassa, H., Takaish, Y. & Terada, H. (1990) The triterpenecelastrol as a very potent inhibitor of

Schapira, A.H. (1999**)** Mitochondrial involvement in Parkinson's disease, Huntington's disease,

Schapira, A.H. (2009) Neurobiology and treatment of Parkinson's disease. *Trends in Pharmacological Sciences*, Vol.30, No.1, (January 2009), pp. 41–47, ISSN 0165-6147 Seeman, P., Caruso, C. & Lasaga, M. (2008) Memantine agonist action at dopamine D2High

Sengupta, T., Vinayagam, J., Nagashayana, N., Gowda, B., Jaisankar, P. & Mohanakumar, K.P.

Skolimowski, J., Kochman, A. & Metodiewa, D. (2003) Synthesis and antioxidant activity

Spilker, B.A., Dhasmana, K.M., Davies, J.E. & Claassen, V. (1973) Differentiation between effects

Sulzer, D. & Schmitz, Y. (2007) Parkinson's disease: return of an old prime suspect. *Neuron*,

Tymianski, M., Charlton, M.P., Carlen, P.L. & Tator, C.H. (1993) Source specificity of early

Velena, A., Skujins. A., Svirskis, S., Bisenieks, E., Uldrikis, J., Poikans, J., Duburs, G. & Klusa, V.

Vicente, J.A.F., Duburs, G., Klusa, V., Briede, J., Klimaviciusa, L., Zharkovsky, A. & Fernandez,

*Thérapie*, Vol.203, No.2, (June 1973), pp. 221-231, ISSN 0301-4533

Vol.55, No.1, (July 2007), pp. 8-10, ISSN 0896-6273

(September 1997), pp. 211–220, ISSN 0263-6484

Research Network, ISBN 8178952076, Kerala, India

(May 2010), pp. 600-606, ISSN 0364-5134

(June 2008), pp. 208-217, ISSN 0006-8993

0887-4476

3190

3539, ISSN 0968-0896

ISSN 0270-6474

Vol.172, No2, (October 1990), pp. 890-897, ISSN 0006-291X

Vol.*1410*, No.2, (February 1999), pp. 159–170, ISSN 0006-3002

channel blockers and Parkinson disease in Denmark. *Annals of Neurology,* Vol.67, No.5,

mouse model of retinal degeneration induced by rotenone. *Brain Research*, Vol.1215,

lipid peroxidation in mitochondria. *Biochemical and Biophysical Research Communications,*

hereditary spastic paraplegia and Friedreich's ataxia. *Biochimica et Biophysica Acta*,

receptors. *Synapse (New York, N.Y.),* Vol.62, No.2, (February 2008), pp. 149-153, ISSN

(2011) Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency. *Neurochemical Research*, Vol.36, No.1, (January 2010), pp. 177-186, ISSN 0364-

evaluation of novel antiparkinsonian agents, aminoadamantane derivatives of nitroxyl free radical. *Bioorganic & Medicinal Chemistry,* Vol.11, No.16, (August 2003), pp. 3529-

of nicotine and DMPP by amantadine. *Archives Internationales de Pharmacodynamie et de* 

calcium neurotoxicity in cultured embryonic spinal neurons. *The Journal of Neuroscience : the Official Journal of the Society for Neuroscience,* Vol.13, No.5, (May 1993), pp. 2085-2104,

(1997) Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, cerebrocrast and glutapyrone, themselves and in the presence of azidothymidine. *Cell Biochemistry and Function*, Vol.15, No.3,

M.A.S. (2006) Cerebrocrast as a neuroprotective, anti-diabetic and mitochondrial bioenergetic effector: A putative mechanism of action, In: *Mitochondrial Pharmacology and Toxicology*, A.J.M. Moreno, P.J. Oliveira & C.M. Palmiera (Eds.), 185-197, Transworld
